NAV
₹36.4768
as of 30 Sept 2026
Expense Ratio
1.37%
Lumpsum returns (CAGR)
- 1Y
- +14.89%
- 3Y
- +20.96%
- 5Y
- +12.05%
- Since Inception
- +18.63%
SIP returns (XIRR)
- 1Y
- +19.46%
- 3Y
- +15.59%
- 5Y
- +17.23%
- Since Inception
- +17.67%
Returns calculated from 28 February 2019 onwards due to a structural change in the scheme on that date. Earlier NAV history is preserved but excluded from multi-year return calculations. Periods spanning this date show —.
Performance Comparison
Sectoral allocation
as of 31 Aug 2026Each sector links to the mutual funds most exposed to it.
Thinking about LIC MF Healthcare Fund · Direct · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Portfolio holdings
portfolio shared with LIC MF Healthcare Fund-Regular Plan-Growth
- 1Sun Pharmaceutical Industries Ltd.10.09%
- 2Divi'S Laboratories Ltd.9.29%
- 3Torrent Pharmaceuticals Ltd.6.45%
- 4Neuland Laboratories Ltd.6.38%
- 5Apollo Hospitals Enterprise Ltd.6.23%
- 6Navin Fluorine International Ltd.5.65%
- 7Aurobindo Pharma Ltd.5.17%
- 8Aster Dm Quality Care Ltd.4.82%
- 9Zydus Lifesciences Ltd.4.79%
- 10Gland Pharma Ltd.3.93%
What this fund does
LIC MF Healthcare Fund · Direct · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
LIC MF Healthcare Fund · Direct · Growth is a Sectoral / Thematic mutual fund offered by LIC Mutual Fund. The fund has been operational for over 7 years. The current expense ratio is 1.37%.